Kirsten Fischer
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 31, 2024
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.Othman Al-Sawaf, Sandra Robrecht, Can Zhang
|Dec 09, 2023
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.Othman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht
|Oct 23, 2023
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.Othman Al-Sawaf, Can Zhang, Hyun Yong Jin
|Apr 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.Othman Al-Sawaf, Can Zhang, Hyun Yong Jin
Pageof 1
Frequent Collaborators
4 joint publications
Othman Al-Sawaf
3 joint publications
Stephan Stilgenbauer
2 joint publications
Christian P Pallasch
2 joint publications
Martin Peifer
2 joint publications
Michael Hallek
2 joint publications
Carsten Utoft Niemann
1 joint publications
Rudy Ligtvoet
1 joint publications
Johannes Schetelig
1 joint publications
Philipp Staber
1 joint publications
Javier Loscertales
